Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use POTELIGEO safely and effectively. See full prescribing information for POTELIGEO. POTELIGEO® (mogamulizumab-kpkc) injection, for intravenous useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.
- generic_name
- mogamulizumab-kpkc
- product_names
- mogamulizumab-kpkc
- ndc
- 42747-761, 42747-761-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en